PT2579866T - Administração intravaginal de misoprostol - Google Patents

Administração intravaginal de misoprostol

Info

Publication number
PT2579866T
PT2579866T PT117933119T PT11793311T PT2579866T PT 2579866 T PT2579866 T PT 2579866T PT 117933119 T PT117933119 T PT 117933119T PT 11793311 T PT11793311 T PT 11793311T PT 2579866 T PT2579866 T PT 2579866T
Authority
PT
Portugal
Prior art keywords
misoprostol
intravaginal administration
intravaginal
administration
Prior art date
Application number
PT117933119T
Other languages
English (en)
Inventor
Robertson Steven
l powers Barbara
F De La Cruz Vidal
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PT2579866T publication Critical patent/PT2579866T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PT117933119T 2010-06-11 2011-06-13 Administração intravaginal de misoprostol PT2579866T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35383510P 2010-06-11 2010-06-11

Publications (1)

Publication Number Publication Date
PT2579866T true PT2579866T (pt) 2016-08-19

Family

ID=45098734

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117933119T PT2579866T (pt) 2010-06-11 2011-06-13 Administração intravaginal de misoprostol

Country Status (18)

Country Link
US (1) US20130197081A1 (pt)
EP (1) EP2579866B1 (pt)
JP (2) JP5964294B2 (pt)
KR (1) KR101852913B1 (pt)
CN (1) CN102939085B (pt)
AU (1) AU2011265222B2 (pt)
CA (1) CA2802214A1 (pt)
DK (1) DK2579866T3 (pt)
ES (1) ES2587260T3 (pt)
HK (1) HK1184059A1 (pt)
HU (1) HUE028795T2 (pt)
IL (1) IL223481B (pt)
MX (1) MX339883B (pt)
NZ (1) NZ604064A (pt)
PL (1) PL2579866T3 (pt)
PT (1) PT2579866T (pt)
RU (1) RU2588671C2 (pt)
WO (1) WO2011156812A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339883B (es) * 2010-06-11 2016-06-16 Ferring Bv Administracion intravaginal de misoprostol.
CN102302443B (zh) * 2011-09-21 2014-04-23 天津市聚星康华医药科技有限公司 一种米索前列醇阴道缓释栓剂及其制备方法
EP2689802A1 (en) 2012-07-26 2014-01-29 Ferring B.V. Misoprostol formulation
WO2014016390A1 (en) * 2012-07-26 2014-01-30 Ferring B.V. Misoprostol formulation
EP2754442A1 (en) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol for the induction of labour
EP2689781A1 (en) 2012-07-26 2014-01-29 Ferring B.V. Misoprostol composition
EP2754443A1 (en) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol for the induction of labour
JP2015522646A (ja) * 2012-07-26 2015-08-06 フェリング ベスローテン フェンノートシャップ ミソプロストール組成物
CA2954086C (en) 2014-07-11 2020-03-31 Azanta Danmark A/S Misoprostol dispersible tablet
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
WO2018009789A1 (en) * 2016-07-08 2018-01-11 Vanderbilt University Treatment and prevention of clostridium difficile colitis using misoprostol
CN108753898A (zh) * 2018-04-09 2018-11-06 深圳市祥根生物科技有限公司 一种米索前列醇酸的制备方法及其用途
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017382A (en) * 1979-03-21 1991-05-21 National Research Development Corporation Controlled release compositions (II)
US20020031513A1 (en) * 1997-11-24 2002-03-14 Shamir Leibovitz Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US20090269480A1 (en) * 2008-04-24 2009-10-29 Medtronic Vascular, Inc. Supercritical Fluid Loading of Porous Medical Devices With Bioactive Agents
WO2010036878A1 (en) * 2008-09-26 2010-04-01 The Trustees Of Columbia University In The City Of New York Use of trpv1 receptor agonists in cervical pain and labor
RU2408375C1 (ru) * 2009-06-04 2011-01-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта Северо-Западного отделения РАМН Способ подготовки к родам беременных с преждевременным излитием околоплодных вод при доношенном сроке
MX339883B (es) * 2010-06-11 2016-06-16 Ferring Bv Administracion intravaginal de misoprostol.

Also Published As

Publication number Publication date
JP2016164167A (ja) 2016-09-08
EP2579866A4 (en) 2013-12-04
PL2579866T3 (pl) 2017-01-31
KR20130109099A (ko) 2013-10-07
RU2012154445A (ru) 2014-07-20
AU2011265222A1 (en) 2013-05-23
AU2011265222B2 (en) 2015-04-02
HK1184059A1 (zh) 2014-01-17
CN102939085B (zh) 2016-05-04
EP2579866B1 (en) 2016-05-18
KR101852913B1 (ko) 2018-04-27
NZ604064A (en) 2014-10-31
DK2579866T3 (en) 2016-08-29
MX339883B (es) 2016-06-16
EP2579866A2 (en) 2013-04-17
WO2011156812A2 (en) 2011-12-15
JP6262787B2 (ja) 2018-01-17
MX2012014413A (es) 2013-02-26
IL223481B (en) 2018-11-29
JP5964294B2 (ja) 2016-08-03
CN102939085A (zh) 2013-02-20
ES2587260T3 (es) 2016-10-21
WO2011156812A3 (en) 2012-04-19
US20130197081A1 (en) 2013-08-01
CA2802214A1 (en) 2011-12-15
HUE028795T2 (en) 2017-01-30
JP2013528231A (ja) 2013-07-08
RU2588671C2 (ru) 2016-07-10

Similar Documents

Publication Publication Date Title
HRP20181615T1 (hr) Terapijsko sredstvo koje izaziva citotoksičnost
HK1184059A1 (zh) 陰道內施用米索前列醇
GB201010193D0 (en) Medicinal use
EP2387394A4 (en) TRANSDERMAL ADMINISTRATION OF TAMSULOSIN
IL226298A0 (en) Intravaginal devices for the controlled administration of lubricants
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
HK1197027A1 (en) Use of estetrol as emergency contraceptive
PL2648696T3 (pl) Nowa forma podawania racekadotrylu
EP2552210A4 (en) FORMULAS FROM MAZINDOL
IL223437B (en) Secreting condom
EP2605795A4 (en) INTRAVAGINAL DEVICES AND METHOD FOR THEIR MANUFACTURE AND USE
SI2407155T1 (sl) Preparati na osnovi inekalcitola
EP2647386A4 (en) Lissencephaly THERAPEUTIC
SI2536400T1 (sl) Zdravilo, ki vsebuje miramistin
GB201001203D0 (en) Use of pharmaceutically active compounds
EP2668961A4 (en) PHARMACEUTICAL COMBINATION PREPARATION
PL390434A1 (pl) Preparat leczniczy
GB201003727D0 (en) Therapeutic agent
GB201003342D0 (en) Manufacture of insoluble drugs
TWM402097U (en) Improved condom structure
GB201001317D0 (en) Medicament
PL390620A1 (pl) Preparat farmaceutyczny
TWM389548U (en) Improved structure of soft capsule
AU332227S (en) Therapeutic pillow
AU2010900699A0 (en) Therapeutic Uses of SLIRP